Brought to you by 
GSK to market Labtec's cold sore patch
23 Jun 2010
Executive Summary
Transdermal drug delivery company Labtec GMBH (a Beiersdorf AG subsidiary) has licensed GlaxoSmithKline Consumer Healthcare exclusive rights to market a new topical patch to treat cold sores.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK to market Labtec's cold sore patch
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice